In addition, it has been reported that the majority of DIPG tumors were positive for EGFR and p53, suggesting that deregulation of EGFR and p53 may play an important role in the development of DIPG and therefore therapies targeting these proteins might be beneficial in the treatment of DIPG [55]. This evidence concerns the gene TP53 and diffuse intrinsic pontine glioma.